The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blue Biotechnology Market Research Report 2024
Synopsis
Blue biotechnology is the application of molecular biological methods to marine and freshwater organisms. These organisms are used for purposes like increasing seafood supply and safety, controlling the reproduction of dangerous water-borne organisms, and developing new drugs.
The global Blue Biotechnology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Blue Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Blue Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Blue Biotechnology in Bio-Engineering is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Blue Biotechnology include Aker BioMarine, Marinova, New England Biolabs, PML Applications, Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products and GeoMarine Biotechnologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Blue Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Biotechnology.
Report Scope
The Blue Biotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blue Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blue Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aker BioMarine
Marinova
New England Biolabs
PML Applications
Sea Run Holdings
PICES
Donald Danforth Plant Science Center
Shell Marine Products
GeoMarine Biotechnologies
GlycoMar
Cellgen Biologicals
Nurture Aqua Technology
Samudra Biopharma
Sanosil Biotech
Segment by Type
Enzymes
Pharma Products
Bulk Chemicals
Biopolymers
Segment by Application
Bio-Engineering
Genomics
Vaccine Development
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blue Biotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Blue biotechnology is the application of molecular biological methods to marine and freshwater organisms. These organisms are used for purposes like increasing seafood supply and safety, controlling the reproduction of dangerous water-borne organisms, and developing new drugs.
The global Blue Biotechnology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Blue Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Blue Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Blue Biotechnology in Bio-Engineering is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Blue Biotechnology include Aker BioMarine, Marinova, New England Biolabs, PML Applications, Sea Run Holdings, PICES, Donald Danforth Plant Science Center, Shell Marine Products and GeoMarine Biotechnologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Blue Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Biotechnology.
Report Scope
The Blue Biotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blue Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blue Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aker BioMarine
Marinova
New England Biolabs
PML Applications
Sea Run Holdings
PICES
Donald Danforth Plant Science Center
Shell Marine Products
GeoMarine Biotechnologies
GlycoMar
Cellgen Biologicals
Nurture Aqua Technology
Samudra Biopharma
Sanosil Biotech
Segment by Type
Enzymes
Pharma Products
Bulk Chemicals
Biopolymers
Segment by Application
Bio-Engineering
Genomics
Vaccine Development
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blue Biotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blue Biotechnology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enzymes
1.2.3 Pharma Products
1.2.4 Bulk Chemicals
1.2.5 Biopolymers
1.3 Market by Application
1.3.1 Global Blue Biotechnology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bio-Engineering
1.3.3 Genomics
1.3.4 Vaccine Development
1.3.5 Drug Discovery
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blue Biotechnology Market Perspective (2019-2030)
2.2 Blue Biotechnology Growth Trends by Region
2.2.1 Global Blue Biotechnology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blue Biotechnology Historic Market Size by Region (2019-2024)
2.2.3 Blue Biotechnology Forecasted Market Size by Region (2025-2030)
2.3 Blue Biotechnology Market Dynamics
2.3.1 Blue Biotechnology Industry Trends
2.3.2 Blue Biotechnology Market Drivers
2.3.3 Blue Biotechnology Market Challenges
2.3.4 Blue Biotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blue Biotechnology Players by Revenue
3.1.1 Global Top Blue Biotechnology Players by Revenue (2019-2024)
3.1.2 Global Blue Biotechnology Revenue Market Share by Players (2019-2024)
3.2 Global Blue Biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blue Biotechnology Revenue
3.4 Global Blue Biotechnology Market Concentration Ratio
3.4.1 Global Blue Biotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blue Biotechnology Revenue in 2023
3.5 Blue Biotechnology Key Players Head office and Area Served
3.6 Key Players Blue Biotechnology Product Solution and Service
3.7 Date of Enter into Blue Biotechnology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blue Biotechnology Breakdown Data by Type
4.1 Global Blue Biotechnology Historic Market Size by Type (2019-2024)
4.2 Global Blue Biotechnology Forecasted Market Size by Type (2025-2030)
5 Blue Biotechnology Breakdown Data by Application
5.1 Global Blue Biotechnology Historic Market Size by Application (2019-2024)
5.2 Global Blue Biotechnology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blue Biotechnology Market Size (2019-2030)
6.2 North America Blue Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blue Biotechnology Market Size by Country (2019-2024)
6.4 North America Blue Biotechnology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blue Biotechnology Market Size (2019-2030)
7.2 Europe Blue Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blue Biotechnology Market Size by Country (2019-2024)
7.4 Europe Blue Biotechnology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blue Biotechnology Market Size (2019-2030)
8.2 Asia-Pacific Blue Biotechnology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blue Biotechnology Market Size by Region (2019-2024)
8.4 Asia-Pacific Blue Biotechnology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blue Biotechnology Market Size (2019-2030)
9.2 Latin America Blue Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blue Biotechnology Market Size by Country (2019-2024)
9.4 Latin America Blue Biotechnology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blue Biotechnology Market Size (2019-2030)
10.2 Middle East & Africa Blue Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blue Biotechnology Market Size by Country (2019-2024)
10.4 Middle East & Africa Blue Biotechnology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aker BioMarine
11.1.1 Aker BioMarine Company Detail
11.1.2 Aker BioMarine Business Overview
11.1.3 Aker BioMarine Blue Biotechnology Introduction
11.1.4 Aker BioMarine Revenue in Blue Biotechnology Business (2019-2024)
11.1.5 Aker BioMarine Recent Development
11.2 Marinova
11.2.1 Marinova Company Detail
11.2.2 Marinova Business Overview
11.2.3 Marinova Blue Biotechnology Introduction
11.2.4 Marinova Revenue in Blue Biotechnology Business (2019-2024)
11.2.5 Marinova Recent Development
11.3 New England Biolabs
11.3.1 New England Biolabs Company Detail
11.3.2 New England Biolabs Business Overview
11.3.3 New England Biolabs Blue Biotechnology Introduction
11.3.4 New England Biolabs Revenue in Blue Biotechnology Business (2019-2024)
11.3.5 New England Biolabs Recent Development
11.4 PML Applications
11.4.1 PML Applications Company Detail
11.4.2 PML Applications Business Overview
11.4.3 PML Applications Blue Biotechnology Introduction
11.4.4 PML Applications Revenue in Blue Biotechnology Business (2019-2024)
11.4.5 PML Applications Recent Development
11.5 Sea Run Holdings
11.5.1 Sea Run Holdings Company Detail
11.5.2 Sea Run Holdings Business Overview
11.5.3 Sea Run Holdings Blue Biotechnology Introduction
11.5.4 Sea Run Holdings Revenue in Blue Biotechnology Business (2019-2024)
11.5.5 Sea Run Holdings Recent Development
11.6 PICES
11.6.1 PICES Company Detail
11.6.2 PICES Business Overview
11.6.3 PICES Blue Biotechnology Introduction
11.6.4 PICES Revenue in Blue Biotechnology Business (2019-2024)
11.6.5 PICES Recent Development
11.7 Donald Danforth Plant Science Center
11.7.1 Donald Danforth Plant Science Center Company Detail
11.7.2 Donald Danforth Plant Science Center Business Overview
11.7.3 Donald Danforth Plant Science Center Blue Biotechnology Introduction
11.7.4 Donald Danforth Plant Science Center Revenue in Blue Biotechnology Business (2019-2024)
11.7.5 Donald Danforth Plant Science Center Recent Development
11.8 Shell Marine Products
11.8.1 Shell Marine Products Company Detail
11.8.2 Shell Marine Products Business Overview
11.8.3 Shell Marine Products Blue Biotechnology Introduction
11.8.4 Shell Marine Products Revenue in Blue Biotechnology Business (2019-2024)
11.8.5 Shell Marine Products Recent Development
11.9 GeoMarine Biotechnologies
11.9.1 GeoMarine Biotechnologies Company Detail
11.9.2 GeoMarine Biotechnologies Business Overview
11.9.3 GeoMarine Biotechnologies Blue Biotechnology Introduction
11.9.4 GeoMarine Biotechnologies Revenue in Blue Biotechnology Business (2019-2024)
11.9.5 GeoMarine Biotechnologies Recent Development
11.10 GlycoMar
11.10.1 GlycoMar Company Detail
11.10.2 GlycoMar Business Overview
11.10.3 GlycoMar Blue Biotechnology Introduction
11.10.4 GlycoMar Revenue in Blue Biotechnology Business (2019-2024)
11.10.5 GlycoMar Recent Development
11.11 Cellgen Biologicals
11.11.1 Cellgen Biologicals Company Detail
11.11.2 Cellgen Biologicals Business Overview
11.11.3 Cellgen Biologicals Blue Biotechnology Introduction
11.11.4 Cellgen Biologicals Revenue in Blue Biotechnology Business (2019-2024)
11.11.5 Cellgen Biologicals Recent Development
11.12 Nurture Aqua Technology
11.12.1 Nurture Aqua Technology Company Detail
11.12.2 Nurture Aqua Technology Business Overview
11.12.3 Nurture Aqua Technology Blue Biotechnology Introduction
11.12.4 Nurture Aqua Technology Revenue in Blue Biotechnology Business (2019-2024)
11.12.5 Nurture Aqua Technology Recent Development
11.13 Samudra Biopharma
11.13.1 Samudra Biopharma Company Detail
11.13.2 Samudra Biopharma Business Overview
11.13.3 Samudra Biopharma Blue Biotechnology Introduction
11.13.4 Samudra Biopharma Revenue in Blue Biotechnology Business (2019-2024)
11.13.5 Samudra Biopharma Recent Development
11.14 Sanosil Biotech
11.14.1 Sanosil Biotech Company Detail
11.14.2 Sanosil Biotech Business Overview
11.14.3 Sanosil Biotech Blue Biotechnology Introduction
11.14.4 Sanosil Biotech Revenue in Blue Biotechnology Business (2019-2024)
11.14.5 Sanosil Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
